Platelet-activating factor inhibits ciliary beat frequency of human bronchial epithelial cells

Related Experiment Video

Updated: Oct 23, 2026

Collection, Expansion, and Differentiation of Primary Human Nasal Epithelial Cell Models for Quantification of Cilia Beat Frequency
11:13

Collection, Expansion, and Differentiation of Primary Human Nasal Epithelial Cell Models for Quantification of Cilia Beat Frequency

Published on: November 10, 2021

U Klettke1, W Luck, U Wahn

  • 1Division of Pediatric Pneumology and Immunology, Charité, Humboldt University, Berlin, Germany.

Allergy and Asthma Proceedings
|April 21, 1999
PubMed

Insights

Platelet-activating factor (PAF) reduces human bronchial ciliary beat frequency, impairing mucociliary clearance. A PAF inhibitor reversed this effect, indicating PAF

Area of Science:

  • Respiratory Medicine
  • Immunology
  • Cell Biology

Background:

  • Mucociliary clearance is vital for airway defense.
  • Airway inflammation involves various mediators.
  • Platelet-activating factor (PAF) is implicated in inflammatory processes.

Purpose of the Study:

  • To investigate the impact of platelet-activating factor (PAF) on human bronchial ciliary beat frequency (CBF) ex vivo.
  • To determine if PAF affects mucociliary clearance.
  • To assess the role of PAF in airway inflammation.

Main Methods:

  • Human bronchial brush biopsies were obtained from pediatric patients.
  • Ciliary beat frequency (CBF) was measured using phase-contrast microscopy and a photoelectric technique.
  • Ex vivo application of PAF (10(-5) M) and its inhibitor WEB 2086 (10(-4) M) to assess their effects on CBF.

Main Results:

  • Platelet-activating factor (PAF) significantly reduced mean CBF by 2.1 Hz to 9.2 Hz (p < 0.05).
  • The PAF-induced decrease in CBF was completely reversed by the PAF-inhibitor WEB 2086.
  • WEB 2086 alone did not significantly alter CBF, confirming its specificity.

Conclusions:

  • Platelet-activating factor (PAF) directly inhibits human bronchial ciliary beat frequency.
  • PAF contributes to the impairment of mucociliary clearance.
  • Targeting PAF may be a therapeutic strategy for airway inflammatory conditions.

More Related Videos

Optimal Lentivirus Production and Cell Culture Conditions Necessary to Successfully Transduce Primary Human Bronchial Epithelial Cells09:12

Optimal Lentivirus Production and Cell Culture Conditions Necessary to Successfully Transduce Primary Human Bronchial Epithelial Cells

Published on: July 22, 2016

Determining Ciliary Function and Membrane Impermeability of the Pseudostratified Lung Airway Epithelium07:40

Determining Ciliary Function and Membrane Impermeability of the Pseudostratified Lung Airway Epithelium

Published on: February 21, 2025

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...